GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
USGLX
Price
$63.83
Change
-$0.83 (-1.28%)
Updated
Nov 13 closing price
Net Assets
1.8B
Interact to see
Advertisement

GFACX vs USGLX

Header iconGFACX vs USGLX Comparison
Open Charts GFACX vs USGLXBanner chart's image
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
JHancock U.S. Global Leaders Growth A
Price$63.83
Change-$0.83 (-1.28%)
VolumeN/A
Net Assets1.8B
GFACX vs USGLX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. USGLX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and USGLX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. USGLX (1.8B). GFACX (0.00) and USGLX (0.00) have matching dividends . GFACX was incepted earlier than USGLX: GFACX (25 years) vs USGLX (30 years). GFACX (1.36) is less costly to investors than USGLX (1.14). USGLX is a more actively managed with annual turnover of: 29.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than USGLX: GFACX (250) vs USGLX (1000). GFACX annual gain was more profitable for investors over the last year : 4.61 vs. USGLX (-15.51). GFACX return over 5 years is better than : 27.87 vs. USGLX (-4.62).
GFACXUSGLXGFACX / USGLX
Total Expense Ratio1.361.13120%
Annual Report Gross Expense Ratio1.361.14119%
Fund Existence25 years30 years-
Gain YTD16.3431.5231,073%
Front LoadN/A5%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets340B1.8B18,878%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.61-15.51-30%
Returns for 3 years56.1727.79202%
Returns for 5 years27.87-4.62-604%
Returns for 10 years75.7850.76149%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics